Mice. For conventionalization, cecal contents were collected aseptically from 8 to 15
Tissue analyses. Adipose tissues, livers, ileum, colon and cecal tissues and contents were frozen in liquid nitrogen. Visceral adipose tissue was dissected as described by Caesar et al. (2) . A portion of subcutaneous and visceral adipose tissue was fixed in RNA Later (Ambion, Life Technologies, Grand Island, NY). All samples were stored at -80°C until further use. Gene expression analyses were performed as previously described (3) using RealMasterMix SYBR ROX (5Prime, Gaithersburg, MD) or Maxima SYBR Green qPCR Master Mix (Thermo Scientific, Waltham, MA) and a Mastercycler ep realplex (Eppendorf AG, Hamburg, Germany) for detection and RPL4 as a housekeeping gene. RNA quality was checked for a subset of samples using an Agilent 2100 Bioanalyzer according to manufacturer's instructions (Agilent Technologies, Santa Clara, CA). For visceral adipose tissue, all samples were analyzed for RNA quality. Eight out of the 63 samples of visceral adipose tissue presented a RIN <5 and were discarded from the analyses.
Primer sequences are provided in Table A .
Flow cytometry. Flow cytometric analysis of the stromal vascular fraction (SVF) from subcutaneous adipose tissue was performed using published protocols (4) (5) (6) . Briefly, lymph nodes were removed and one g of adipose tissue was minced in KREB-BSA, digested using Collagenase I (Worthington, Lakewood, NJ) for 40 min at 37°C, filtered and washed. Red blood cells were removed using ACK lysis buffer. SVF cells were quantified using a cellometer with acridine orange and propidium iodide (Nexcelom Bioscience LLC, Lawrence, MA) prior to being labeled with PE F4/80 (clone BM8), PE-Cy7 CD11c (clone N418), APC-Cy7 CD11b (clone M1/70), PerCP-Cy5.5 CD206 (clone C068C2; Biolegend, San Diego, CA), APC CD301 (clone ER-MP23; AbD Serotec, Raleigh, NC) and PE-Texas Red CD45.2 (clone 104). All antibodies were obtained from eBioscience (San Diego, CA) unless otherwise noted. Cells were analyzed using a BD FACSAria III (BD Biosciences, San Jose, CA). Data were analyzed using FlowJo X 10.0.7 (Tree star, Ashland, OR); gates were drawn based on fluorescence minus one controls.
Microbial community analysis. Gut microbiota composition was assessed by 16S rRNA gene sequencing of fecal samples as previously described (7) . Genomic DNA was extracted from feces using a QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA) with a bead-beating step.
Amplicon sequencing of the fecal microbiota was done at the University of Minnesota Genomics Center, as described in the supplemental methods. Briefly, the V5-V6 region of the 16S rRNA gene was PCR-enriched using the primer pair 784F (5'-RGGATTAGATACCC-3') and by PicoGreen and normalized to 2 nM for input into Illumina MiSeq (v3 Kit) to produce 2x300 bp sequencing products. Clustering was done at 10 pM with a 5% spike of PhiX.
The sequences used for analysis can be found in the MG-RAST database (8) Bile acids analysis. Forty-six bile acids were quantified by ultrahigh performance liquid chromatography -multiple-reaction monitoring mass spectrometry (UPLC-MRM-MS) at the University of Victoria Genome British Columbia Proteomics Centre using a protocol adapted from Han et al. (9) . In brief, the cecal contents were homogenized in water at a ratio of 150 μL per 10 mg raw material at a shaking frequency of 30 Hz for 1 min twice with the aid of two 5-mm stainless steel metal balls using a Restch MM 400 mixer mill (Haan, Germany). Bile acids were extracted by addition of acetonitrile at a ratio of 350 μL per 10 mg raw material followed by vortex mixing and 1-min sonication in an ice water bath. The samples were centrifuged at 12,500 rpm for 10 min (Table B) . After addition of 430 μL of 70% acetonitrile and 10 μL of 10% formic acid, the mixtures were cleaned up by phospholipid-depletion solid-phase extraction on a HybridSPE®-Phospholipid 96-well plate (50 mg/2 mL; Sigma-Aldrich) using the same procedure as described in (13). The flow-through fractions were collected and then dried under a gentle nitrogen flow. The residues were dissolved in 200 μL of 50% methanol. Ten-μL aliquots were injected. For the analysis of the high abundance bile acids, the samples were diluted 25 times and then re-injected. The UPLC-MRM/MS analyses were performed using a Dionex UltiMate 3400 RSLC system (Amsterdam, The Netherlands) coupled to an AB Sciex 4000 QTRAP mass spectrometer (Concord, ON, Canada) equipped with a TurboIon electrospray ionization (ESI) source and operated in the negative ion multiple-reaction monitoring (MRM) mode. UPLC separation was carried out on a Waters BEH C18 UPLC column (2.1 x 150 mm, 1.7 μm) with water-acetonitrile-0.01% formic acid as the mobile phase for binary gradient elution using the same UPLC and MRM/MS parameters and operating procedures as described in (9) .
Concentrations of the detected bile acids (Table B) were calculated with internal calibration from their linearly regressed standard curves prepared using the authentic compounds of 46 bile acids. Since taurohyodeoxycholic acid and tauroursodeoxycholic acid were not resolved by UPLC-MRM/MS, the total amount of these two compounds in each sample was reported as the concentration of tauroursodeoxycholic acid. The 14 D-labeled bile acids were used as IS for their corresponding non-D-labeled forms. For the bile acids without their D-labeled analogues, chenodeoxycholic-D4 acid was used as the common IS for quantitation of the unconjugated species; tauro-chenodeoxycholic-D4 acid was used as the common IS for quantitation of the taurineconjugated species; glyco-deoxycholic-D4 acid was used as the common IS for quantitation of the glycine-conjugated species. Since there were no standard compounds available for glyco-ω-muricholic acid (MCA), glyco-α-MCA, glyco-β-MCA or glyco-allocholic acid, the identities of these compounds, which shared the same MRM transitions as those of their isomeric glycocholic acid, were deduced from the recorded chromatographic retention times by comparison of the retention times of their corresponding unconjugated and taurine-conjugated species on the acquired UPLC-MRM/MS profiles. The concentrations of glyco-ω-MCA, glyco-α-MCA, glyco-β-MCA, and glyco-allocholic acid were calculated from the calibration curve of glycocholic acid. In the analysis, the lower limits of quantification were 0.005 nmole/g. 
